Opus Genetics targets inherited retinal diseases with one-dose AAV gene augmentations. Read why IRD stock is a Buy.
Dim indoor light and prolonged close focus may be quietly fueling the global rise in nearsightedness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results